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The American College of Cardiology (ACC) recognizes the
important role that catheter ablation has assumed in the treat-
ment of arrhythmias, as reflected in this review of the background
and current applications of ablative procedures. The following
position statement evolved from a document by the North
American Society of Pacing and Electrophysiology (NASPE) (1)
but has been substantially modified and updated.
Catheter ablation for control of cardiac arrhythmias was
first introduced more than a decade ago . Since then these
procedures have largely supplanted the need for expensive and
potentially more dangerous open heart surgical procedures for
several types of arrhythmias. Catheter ablative procedures
constitute a widely practiced, nonpharmacologic technique for
management of patients with supraventricular tachycardia and
selected ventricular tachycardias. The current CPT codes for
Intracardiae Catheter Ablation (93650, 93651 and 93652) do
not compensate for ablative procedures, except by local option .
The ACC believes that routine reimbursement for ablative
procedures would now seem appropriate in view of the matu-
ration and clinical utility of the technique, as demonstrated by
its safety, efficacy and cost-effectiveness.
Definition of Terms and Methods
of Procedure
Ablation refers to the intentional destruction of arrhythmo-
genic myocardial tissue, accessory atrioventricular (AV) con-
nections or parts of the specialized conduction system to cure
or control cardiac rhythm disturbances . Ablative procedures
may be performed by using surgical or electrode catheter
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methods or by delivery of pharmacologic substances to the
target region .
Catheter ablative procedures at present involve delivery of
energy pulses by means of electrode catheters of the standard
type used for electrophysiologic studies or as modified with
larger surface area tips and other design features . Radiofre-
quency has largely replaced direct current shock as the energy
source. The methods of procedure vary depending on the type
of arrhythmia treated and include ablation of the AV junction,
modification of the AV node or perinodal areas, ablation of
accessory AV pathways and ablation of atrial or ventricular
tissue. Ablation of the AV junction to produce complete AV
block involves insertion of an electrode catheter in the region
of the AV junction with delivery of radiofrequency current to
interrupt impulse transmission from atrium to ventricle . Mod-
ification of the AV node is used to eliminate AV node
reentrant tachycardia while leaving AV node conduction in-
tact. For patients with accessory AV connections, the catheter
is placed in close approximation to the accessory pathway to
desiccate this tissue by delivery of radiofrequency energy
pulses
. After appropriate mapping and localization of sites of
ectopic impulse formation or location of the right bundle
branch in cases of bundle branch reentrant ventricular tachy-
cardia, radiofrequency pulses can be delivered to terminate the
tachycardia . A detailed report (2) by the Diagnostic and
Therapeutic Technology Assessm :nt panel (DATTA) of the
American Medical Association can be reviewed .
Safety and Efficacy of Catheter
Ablative Procedures
Catheter ablation was first used clinically in 1981 and
initially involved use of high energy direct current shocks for
destruction of the AV junction . Ablative procedures hava been
0735-1197/94/S7.00
JACC Vol . 24, No . 3
September 1494:828-33
used in thousands of patients worldwide . The early results have
been well summarized in a monograph
(3) . The largest single
report of high energy direct current ablation comes from the
Percutancous Catheter Mapping and Ablation Registry
(PCMAR) (4), which accumulated data on 552 patients fol-
lowed up for a mean of 23 ± 18 months. These patients were
intolerant of or failed to respond to a mean of 3
.5 antiarrhyth-
nnic medications . Sixty-four percent of patients had atrial
fibrillation or flutter; 20% had AV node reentrant tachycardia;
and 16% had a variety of supraventricular arrhythmias . Large
series (5,6)
using radiofrequency ablation are now appearing.
Efficacy and safety of
direct current shocks for AV junc-
tional ablation . Sixty-four percent of patients who achieved
third-degree AV block remain without symptoms or need for
antiarrhythmic therapy (4) . However, long-term cardiac pacing
is required
. Eight percent of patients had return of conduction
but with arrhythmia control without symptoms and without
requiring an antiarrhythmic drug (4). Ablation therapy was
considered to have failed in 16% of patients (4).
Acute major complications of high energy direct current
ablation are rare but include induction of ventricular arrhyth-
mias, myocardial perforation, venous thrombosis and myocar-
dial depression . The most seriow in-hospital complication is
polymorphous ventricular tachycardia and occurs in -4% of
patients
. The most serious reported complication is a 1 .8%
incidence of sudden cardiac death, which may occur from 3
days to 6 months after ablation (4) . The causal relation of the
ablative procedure itself and sudden death is unclear . Long-
term outcomes, including proarrhythmia assessment, have
been described (7,8) .
Notably, direct current shocks for abla-
tive procedures have now been largely supplanted by radiofre-
quency technology Direct current shocks may still be useful in
some instances, especially if radiofrequency fails (9,10), and
some developmental work in direct current ablation continues
(11) .
Results of radiofrequency ablation of the AVjunction . The
reported efficacy of radiofrequency ablation for the AV junc-
tion varies from 70% to 95% (5,6,9,10,12,13)
. Data compiled
for 260 consecutive patients who underwent radiofrequency
ablation of the AV junction were supplied to NASPE from five
centers in the United States. Morady et al
. (9) concluded that
radiofrequency ablation was more efficacious and safer than
direct current ablation
. The procedure was successful, as
defined by induction of complete AV block, in 86% to 99% of
patients . Serious complications included late sudden death,
electromechanical dissociation and death and acute myocar-
dial infarction within 1 week after the procedure (9) . Olgin and
Scheinman (10) found that radiofrequency ablation was com-
parable in efficacy and perhaps safer than direct current shock
.
The 1992 NASPE survey (6) reported an experience of 1,600
AV junctional ablations, with 95% success and 1
.3% compli-
cation rates. There were two procedure-related deaths
(0.125%)
. In summary, the radiofrequency technique appears
to be safer and is as effective as direct current shock
. Late
sudden cardiac death has been reported after radi
.ofrequency
ablation (for accessory pathways)
(5) ;
the overall incidence is
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unlikely to exceed that obscived after direct current shock
ablation (4,14) and may in fact be the expected rate in the
patient population studied
. Use of radiofrequency energy
obviates the need for general anesthesia during the ablative
procedure .
Results of catheter ablation of accessory AV connections
.
The worldwide experience using direct current ablation or
destruction of accessory AV connections has been summarized
(2,4) .
The largest reported series using direct current ablation
was reported by Warin et al
. (15), who reported a 96% success
rate in 246 consecutive patients . Significant complications
included a 2% incidence of cardiac tamponade and a 2%
incidence of sudden death ; four patients required permanent
cardiac pacemakers (15) .
Radiofrequency energy has largely supplanted high energy
direct current shocks for ablation of accessory AV connections
(1,2,5,6,16-20) . Of 787 patients (1,2) who underwent at-
tempted radiofrequency ablation of accessory AV connections,
the reported success rate (defined as ablation of pathway
function and tachycardia control without medications) ranged
from 88% to 99%
. Significant acute complications included
coronary arterial spasm in three patients, with myocardial
infarction in one . Two patients had aortic valve damage, and
three had cardiac tamponade requiring pericardiocentesis .
Three instances of AV block were reported in attempted
ablation of septal accessory pathways . Clots in either the right
or left atrium appear to be very infrequent, and only one
systemic and one pulmonary embolus has been reported . The
incidence of emboli appears to be relatively low whether or not
postprocedural anticoagulants are used . For left-sided path-
ways, retrograde and transseptal approaches appear to be
comparable and complementary (20) . The 1992 NASPE survey
(6) reports success rates of 91% in 2,527 left free wall
pathways, 87% in 1,279 septal pathways and 82% in 715 right
free wall pathways
; overall complication and death rates were
2
.1% and 0 .2%, respectively
. Radiofrequency ablation of ac-
cessory pathways has also proved cost-effective (21) .
Results of AV
node modification in patients with AV node
reentrant tachycardia.
Initial reports described the use of
high energy direct current discharges in patients with AV node
reentry (22,23)
. Efficacy in terms of tachycardia cure was
-85%, but the procedure was associated with a 5% to 10%
incidence of AV block in the initial reports
. Selective ablation
of the slow AV node pathway appears to reduce the risk of
complete AV block to
:52% to 3% (6) .
More recently, other
groups have described using radiofrequency energy for AV
node modification (5,24-31)
. Jackman et al
. (24) demon-
strated successful abiatiun of the slow pathway in 78 of 80
patients with symptomatic AV node reentrant tachycardia
guided by identification of a slow pathway clectrogram poten-
tial. Wathen et al
. (25) were successful in another 25 patients
using an anatomically guided approach with radiofrequency
ablation in the corridor of the perinodal region between th
,
e
tricuspid annulus and the orifice of the coronary sinus
. Suc-
cessful modification was defined as completed ablation or
modification of either fast or slow AV node conduction,
830
FISHER ET AL .
ACC POSITION STATEMENT
resulting in tachycardia cure without producing third-degree
AV block. The procedure was found to be successful in 85% to
99% of patients . The chief complication reported was induc-
tion of complete AV block which, as in other series (28),
occurred much more frequently in those patients who under-
went attempted fast pathway ablation. The 1992 NASPE
survey (6) included 3,052 patients undergoing slow pathway
ablation, with success in 96% and successful fast pathway
ablation in 90% of 255 patients . Overall complications were
0.96%, and no procedure-related deaths were reported .
Atrial tachycardia and flutter . In the NASPE survey (6)
the success rate was 75% in 371 patients with atrial tachycardia
and flutter. The majority of the successes were due to elimi-
nation of these arrhythmias. and the remainder included
control of the ventricular rate by AV node modification or
ablation . There was a 0.81'' complication rate and no reported
deaths .
Chronic atrial tachycardia frequently leading to cardiomy-
opathy has been successfully and permanently eradicated by
radiofrequency catheter ablation in 12 young patients (32) .
Successes arc being reported in ablations for atrial (5,33,34)
and sinus node tachycardias (5,34) in adults .
Radiofrequency catheter ablation has successfully termi-
nated and prevented arrhythmia reinduction in the presence of
type I atrial flutter in humans (5,35). In these subjects an area
of slow conduction in the low posteroseptal right atrium was
directly ablated . In some patients, activation mapping of atrial
flutter revealed a counterclockwise reentrant wavefront origi-
nating just interior or posterior to the coronary sinus ostium,
proceeding sispe' lorly in the atrial septum to the right atrial
free wall, inferiorly toward the tricuspid annulus and, finally,
medially between the inferior vena cava and tricuspid annulus .
The ablation sites were located just inferior or posterior to the
coronary sinus ostium and were characterized by discrete
clectrograms before the P wave (35) .
Ventricular tachycardia . Several reports (6,36-41) have
described the success of radiofrequency current catheter abla-
tion in patients with sustained ventricular tachycardia . In
addition to coronary artery disease-related ventricular tachy-
cardia, this technique has been used in patients with sustained
ventricular tachycardia in the presence of bundle branch
reentrant tachycardia (37,38) right ventricular outflow tract
tachycardia (39) and other idiopathic ventricular tachycardias
(40,41).
In the NASPE survey (6) there were 429 patients with
ventricular tachycardia with a successful ablation rate of 71%
overall
; 85% in 224 with structurally normal hearts; 54% in 115
with ischemic disease : and 61% with idiopathic cardiomyopa-
thy
. Complications occurred in 3%, with no reported deaths .
Clinical Applications
Catheter ablation of the AV junction is currently consid-
ered the procedure of choice for patients with drug-resistant
arrhythmias arising from atrial tissue and poorly controlled
ventricular rates, unless primary ablation of the tachycardia
JA('(' Vol. _' 4. No .
September 1994
:825-33
focus is possible . Similarly, catheter ablation of the accessory
AV connection is the procedure of choice for patients with
drug-resistant accessory pathway-mediated tachycardias. The
remarkable efficacy and safety of the latter procedure allows
extension of its use for patients with symptomatic tachycardias
(involving an accessory connection) who refuse long-term
dependence on drug therapy or have drug intolerance . Cath-
eter modification of the AV node is the procedure of choice for
patients intolerant to drugs or with drug-resistant AV node
reentrant tachycardia and may he used in preference to
long-term dependence on drug therapy for symptomatic pa-
tients with AV node reentry . This procedure is clearly prefer-
able to surgery in terms of risk, expense . pain and other
discomfort. With the further relinements in catheter mapping,
radiofrequency ablation for atrial and ventricular Iachyarrhyth-
mias is now possible .
These recommendations are supported by a recent state of
(heart statement by the Subcommittee on l lectrocardiography
and Electrophysiology of the American Heart Association
(42), a NASPE policy statement of which this is an update (1).
peer-reviewed published reports (43 .44 land many others, see
References]), extensive survey data (6) and major textbooks of
cardiology (45-47).
Comparison With Other Techniques
or Procedures
Alternative therapy includes use of drugs for tachycardia
control, antitachycardia pacing, Impiantahle cardioverter-
delibrillators and direct cardiac surgical ablation . Heretofore,
cardiac surgery has been considered the treatment of choice
for patients with drug-resistant supraventricular arrhvthmias
(48,49). Cardiac surgery is very effective but requires an open
heart procedure, a hospital stay of 5 to 8 days and prolonged
convalescence until complete recovery is achieved . Catheter
ablation is preferable to surgery in patients with drsiC-resistant
arrhythmias arising from atrial tissue because it is associated
with lower immediate morbidity and mortality and costs much
less than surgery . Catheter ablation in patients with accessory
pathway-mediated tachycardia or AV node reentrant arrhyth-
mia is curative and thus obviates long-term need for drug
therapy . The catheter approach involves a short hospital stay,
after which the patient resumes normal activities . The hospital
stay can be <_ 1 day in ideal cases, although this is not yet typical
because newly diagnosed and complex cases and those that
require monitoring during drug washout or next-day confirma-
tion electrophysiologic studies all may require a longer hospital
stay .
Drug therapy in patients with resistant arrhythmias who
require multiple drugs may he expensive, especially when
factored over the projected life of younger patients. and are
often associated with adverse effects. Many of the available
drugs are not suitable for pregnant women because of the
potential for teratogenic effects. Drugs often require meticu-
lous attention to proper timing and dosage because missing or
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altering a single dose may place the patient at risk for recurrent
arrhythmias, and many patients are averse to long-term depen-
dence on drug therapy . Antitachycardia pacing is seldom used
today for treatment of supraventricular tachycardias because
1) it does not eliminate the arrhythmia, and patients remain
symptomatic from their arrhythmias or during pacing induced
termination ; 2) it tends to become ineffective during long-term
follow-up (50) ; and 3) application of antitachycardia pacing
puts the patient at risk for induction of atrial fibrillation or
atrial flutter, which may result in life-threatening arrhythmias
for patients with Wolff-Parkinson-White syndrome .
Cost Considerations
Catheter ablation is cost-effective (21,25) . Most supraven-
tricular tachycardias involve a brief hospital stay in a unit with
electrocardiographic monitoring facilities . Initial diagnostic
and, in some patients, follow-up studies to document successful
ablation are also required and may he performed at a referring
institution . The total cost of the ablative procedure itself,
including the physician fee, ranges from $12,000 to $18,000 .
This is approximately one-third the total cost of surgical
treatment (51) .
The length of the ablative procedure, including electro-
physiologic assessment, averages 3 to 6 h but can take > 12 h .
Considering the training, expertise and time required for
catheter ablation, the physician compensation is substantially
less than current rates for comparable intehventional tech-
niques, such as coronary balloon angioplasty. It should be
further emphasized that there is a >90% rate of permanent
cure with the most commonly used catheter ablative proce-
dures (AV junctional modification and accessory pathway
ablation) .
Unanswered Questions and Future Research
Future research will involve development of better mapping
techniques and catheters with better electrode configurations
and improved steerability to allow easier access to sites of
accessory AV connections. In addition, future clinical and
research efforts will focus on refinement of radiofrequency
energy; additional energy sources; more effective ablation of
arrhythmias, such as ventricular tachycardia, to improve the
safety and efficacy of these procedures ; and extension to other
arrhythmias, including atrial fibrillation . The potential long-
term risks of radiation exposure sometimes required for
lengthy procedures need to be more fully assessed (52,53) .
There is need for long-term surveillance of efficacy and
safety of patients undergoing catheter ablation, just as there is
for other forms of therapy, including drugs, surgery and
devices.
Personnel
Physicians. The minimal requirements for physician per-
formance of catheter ablation procedures include completion
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of training for electrophysiology board eligibility . Extrapolat-
ing from published guidelines for general training in clinical
clectrophysiology (54) and the NASPE and ACC committees
were in accord that the physician should have been the primary
operator for a minimum of 30 catheter ablation procedures,
including at least 15 accessory AV connection ablations .
It was considered desirable that two physicians be involved
in complex catheter ablation procedures, particularly those
involving ablation of accessory pathways or ventricular tachy-
cardia. The second physician need not be a trained electro-
physiologist but should be adept in catheter manipulation and
treatment of cardiac emergencies. A cardiology or electrophys-
iology postdoctoral fellow or specially trained registered nurse
or physician assistant could fill this role .
To ensure good quality and continued competence, 1) the
committees considered that the physician should perform ?20
ablative procedures/year, an impression backed by data from
the NASPE survey (6) showing a significantly higher compli-
cation rate in centers performing <20 ablations/year. Antici-
pated success rates should be at Ica'st 80%% for AV junctional
ablation, AV node modification for AV node reentry and
accessory pathway ablation . The success rate for ventricular
tachycardia should be at least 30% hut is highly dependent on
patient selectioa .
Laboratory personnel . Laboratory personnel should in-
clude two nurses (or technicians) . One nurse (or physician
assistant) is required to administer sedation and carefully
monitor vital signs throughout the procedure . The NASPE and
ACC committees considered that ablation procedures should
only be performed in centers with ready availability of cardiac
surgical support and percutaneous transluminal coronary an-
gioplasty teams. It was considered that a cardiac surgeon or
anesthesiologist need not he present but should be available
for emergencies. It is not necessary to perform these proce-
dures in the operating room .
Facilities and equipment . Ablative procedures should be
performed in a facility set up for invasive electrophysiologic
studies . The minimal standards for X-ray equipment should
constitute a rotatable C arm or table with good quality X-ray
image. A video recording system for fluoroscopic images is
recommended. Biplane X-ray equipment is considered to be
desirable but not absolutely necessary . State of the art roent-
genographic equipment is favored to minimize radiation expo-
sure, and duration of radiation should be carefully logged for
all procedures. It was considered that the laboratory should
establish guidelines for total radiation exposure for these
procedures (52,53). A recent study showed that the highest
exposure of radiation was to the posterior ninth thoracic
vertebral body, which received an average of -19 rads (52) .
Radiation experts consider that this degree of exposure would
be associated with a lifetime excess risk of fatal malignancy of
-1/1,000 of dying of a malignancy during their lifetime . It
should be noted that the background risk of dying of a
malignancy is 200/1,000 for a 35-year old person
. This level of
risk was thought to be lower than the risk of alternative
medical or surgical treatment (52) . The laboratory should be
832
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equipped to care for patients with acute coronary complica-
tions (e .g .,
thrombus, coronary artery spasm, cardiac tampon-
ade, coronary dissection). In addition, facilities for both tem-
porary and permanent pacemaker insertion should be
available.
It is recommended that the devices used for such ablation
procedures be utilized in a manner conforming to hospital,
local and national regulations governing their application .
Recommendations
1 . Catheter ablation of the AV junction is recommended as
the procedure of choice in patients with drug-resistant
symptomatic atrial tachyarrhythmias and uncontrolled ven-
tricular rates, when complete AV block is the therapy of
choice .
2. Catheter ablation of accessory pathway or pathways is the
treatment of choice in patients with drug-intolerant or
drug-resistant arrhythmias mediated by accessory pathways .
3. Catheter modification of the AV junction, particularly using
the slow pathway approach, is the treatment of choice in
patients with drug-intolerant or drug-resistant AV node
reentrant tachycardia .
4. These procedures are also recommended as alternative
therapy in patients with symptomatic drug-intolerant or
drug-resistant atria[, sinoatrial and ventricular tachyarrhyth-
mias.
In all four categories, ablation is recommended as therapy
in patients who desire. avoidance of long-term drug therapy . As
these procedures continue to evolve they may become a
treatment of choice for initial therapy or an alternative early
treatment choice for many patients with these arrhythmias.
The Committee appreciates the contributions of Drs. Melvin M . Seheinman .
Warren M . Jackman. Douglas P. Zipes . Mark E
. Josephson, Eric L. Michelson
and others who assisted in the revision process .
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